Biomarker detection & validation

Biomarkers are detectable (and quantifiable) biomolecules (nucleic acids, proteins, metabolites) that are characteristic of a specific physiological or disease state. They are fundamental for early disease screening and therapy monitoring, and biomarker discovery and validation can be enhanced through the use of predictive algorithms using single or multi-omics data.

What do we offer?

Our extensive experience in the development of AI-based algorithms supports the de novo discovery and validation of biomarkers using unique proprietary clinical diagnostic algorithms. Next to making use of single or multi-omics approaches, we are also proficient in the computational integration of additional clinical and pathological data using multi-modality methods.
 
For more information read about our IDx & MDx platform.